De novo treatment-resistant psychosis following thioridazine withdrawal

被引：2

作者：

Bastiampillai, Tarun ^{[1
]}

Fantasia, Robert ^{[2
]}

Nelson, Allan ^{[2
]}

机构：

[1] Flinders Univ S Australia, Dept Psychiat, Adelaide, SA 5001, Australia

[2] Flinders Med Ctr, Adelaide, SA, Australia

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2014年 / 48卷 / 06期

关键词：

DISCONTINUATION; DRUGS;

D O I：

10.1177/0004867413499943

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

收藏

页码：585 / 586

页数：2

相关论文

共 5 条

[1]

Bisset AF, 2002, BRIT MED J, V325, P967

[2] Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs [J].

Davies, SJC ;

Cooke, LB ;

Moore, AG ;

Potokar, J .

BRITISH MEDICAL JOURNAL, 2002, 324 (7352) :1519-1521

[3] Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II [J].

Miller, R. .

CURRENT NEUROPHARMACOLOGY, 2009, 7 (04) :315-330

[4] Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse [J].

Moncrieff, J. .

ACTA PSYCHIATRICA SCANDINAVICA, 2006, 114 (01) :3-13

[5] Outcome of patients after market withdrawal of thioridazine: A retrospective analysis in a nationwide cohort [J].

Purhonen, Maija ;

Koponen, Hannu ;

Tiihonen, Jari ;

Tanskanen, Antti .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (11) :1227-1231